Medial prefrontal cortex infusion of α-flupenthixol attenuates systemic d-amphetamine-induced disruption of conditional discrimination performance in rats

Psychopharmacology

Volumn 192, Issue 3, 2007, Pages 347-355

  Dunn, Michael J ^a   Killcross, Simon ^b  

^a CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

flupenthixol; Conditional discrimination; Conditional relationships; d amphetamine; DA D1 D2 antagonists; Dopamine; Medial prefrontal cortex (mPFC); Schizophrenia

Indexed keywords

DEXAMPHETAMINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FLUPENTIXOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUDITORY STIMULATION; CONTROLLED STUDY; DISCRIMINATION LEARNING; DOSE RESPONSE; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RAT STRAIN; TASK PERFORMANCE;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; DEXTROAMPHETAMINE; DISCRIMINATION LEARNING; DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUPENTHIXOL; MALE; MICROINJECTIONS; PREFRONTAL CORTEX; RATS; RECEPTORS, DOPAMINE; SCHIZOPHRENIA;

EID: 34247857464     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-0714-2     Document Type: Article

References (48)

1. Andreason NC, O'Leary DS, Flaum M, Nopoulos P, Watkins GL, Boles Ponto LL, Hichwa RD (1997) Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients. Lancet 349:1730-1734
2. Barch DM, Carter CS, Braver TS, Sabb FW, MacDonald A 3rd, Noll DC, Cohen JD (2001) Selective deficits in prefrontal cortex function in medication-naïve patients with schizophrenia. Arch Gen Psychiatry 58:280-288
3. Berger B, Gaspar P, Verney C (1991) Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends Neurosci 14:21-27
4. Broersen LM, Heinsbroek RPW, de Bruin JPC, Olivier B (1996) Effects of local application of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition. Biol Psychiatry 40:1083-1090
5. Bussey TJ, Muir JL, Everitt BJ, Robbins TW (1997) Triple dissociation of anterior cingulated, posterior cingulated, and medial frontal cortices on visual discrimination tasks using a touchscreen testing procedure for the rat. Behav Neurosci 111: 920-936
6. Castner SA, Goldman-Rakic PS, Williams GV (2004) Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia. Psychopharmacology 174:111-125
7. Cohen JD, Servan-Schreiber D (1992) Context, cortex, and dopamine: a connectionist approach to behavior and biology in schizophrenia. Psychol Rev 99:45-77
8. Cohen JD, Servan-Schreiber D, Steingard S (1995) Schizophrenic deficits in the processing of context: a test of neural network simulations of cognitive functioning in schizophrenia. Schizophr Res 15:113
9. Dunn MJ, Killcross AS (2006a) Differential attenuation of d-amphetamine-induced disruption of conditional discrimination performance by dopamine and serotonin antagonists. Psychopharmacology 188:183-192
10. Dunn MJ, Killcross AS (2006b) Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance. Behav Brain Res 175:271-277
11. Dunn MJ, Killcross AS (2007) Clozapine, SCH 23390 and α-Flupenthixol but not haloperidol, attenuate phencyclidine-induced disruption of conditional discrimination performance. Psychopharmacology (in press)
12. Dunn MJ, Futter D, Bonardi C, Killcross AS (2005) Attenuation of d-amphetamine-induced disruption of conditional discrimination performance by α-flupenthixol. Psychopharmacology 177: 296-306
13. Ellenbroek BA, Budde S, Cools AR (1996) Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex. Neuroscience 75:535-542
14. 11C-raclopride. Psychopharmacology 92:278-284
15. Gainetdinov RR, Mohn AR, Caron MG (2001) Genetic animal models: focus on schizophrenia. Trends Neurosci 24:527-533
16. 1 receptor in schizophrenia: insights for cognitive function. Psychopharmacology 174:3-16
17. Hedou G, Homberg J, Feldon J, Heidbreder CA (2001) Expression of sensitization to amphetamine and dynamics of dopamine neurotransmission in different laminae of the rat medial prefrontal cortex. Neuropharmacology 40:366-382
18. Heidbreder CA, Foxton R, Cilia J, Hughes ZA, Shah AJ, Atkins A, Hunter AJ, Hagan JJ, Jones DNC (2001) Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation. Psychopharmacology 156:338-351
19. Hertel P, Mathe JM, Nomikos GG, Iurlo M, Mathe AA, Svensson TH (1996) Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat. Behav Brain Res 72:103-114
20. Ingvar DH, Franzen G (1974) Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand 50:425-462
21. Javitt DC, Shelley A-M, Silipo G, Lieberman JA (2000) Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern. Arch Gen Psychiatry 57:1131-1137
22. Jentsch JD, Tran A, Le D, Youngren KD, Roth RH (1997a) Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilisation and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology 17:92-99
23. Jentsch JD, Elsorth JD, Redmond DE Jr, Roth RH (1997b) Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966. J Neurosci 17:1769-1775
24. Louilot A, Le Moal M, Simon H (1989) Opposite influences of dopaminergic pathways to the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens: an in vivo voltammetric study. Neuroscience 29:45-56
25. Maisonneuve IM, Keller RW, Glick SD (1990) Similar effects of D-amphetamine and cocaine on extracellular dopamine levels in medial prefrontal cortex of rats. Brain Res 535:221-226
26. Moghaddam B, Bunney BS (1990) Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from the prefrontal cortex, nucleus accumbens and striatum of the rat: an in vivo microdialysis study. J Neurochem 54:1755-1760
27. Moghaddam B, Roth RH, Bunney BS (1990) Characterization of dopamine release in the rat medial prefrontal cortex as assessed by in vivo microdialysis: comparison to the striatum. Neuroscience 36:669-676
28. Murrin LC (1983) Characteristics of 3H-cis-flupenthixol binding in rat striatum. Life Sci 33:2179-2186
29. Nomikos GG, Iurlo M, Andersson JL, Kiurma K, Svensson TH (1994) Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex. Psychopharmacology 115:147-156
30. Paxinos G, Watson C (1997) The rat brain: in stereotaxic coordinates, 3rd edn. Academic, USA
31. Pehek EA (1999) Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and striatum. J Pharmacol Exp Ther 289:14-23
32. Petrides M (1987) Conditional learning and the primate frontal cortex. In: Perceman E (ed) The frontal lobes revisited. IRBN, New York, pp 91-108
33. Raine A, Lencz T, Reynolds GP, Harrison G, Sheard C, Medley I, Reynolds LM, Cooper JE (1992) An evaluation of structural and functional prefrontal deficits in schizophrenia: MRI and neuropsychological measures. Psychiatry Res 45:123-137
34. Reading PJ, Dunnett SB, Robbins TW (1991) Dissociable roles of the ventral, medial and lateral striatum on the acquisition and performance of a complex visual stimulus-response habit. Behav Brain Res 45:147-161
35. Robbins TW, Giardini V, Jone GH, Reading P, Sahakian BJ (1990) Effects of dopamine depletion from the caudate-putamen and nucleus accumbens septi on the acquisition and performance of a conditional discrimination task. Behav Brain Res 38: 243-261
36. Robinson TE, Becker JB, Moore CJ, Castaneda E, Mittleman G (1985) Enduring enhancement in frontal cortex dopamine utilization in an animal model of amphetamine psychosis. Brain Res 343:374-377
37. Seamans JK, Yang CR (2004) The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74:1-58
38. Servan-Schreiber D, Cohen JD, Steingard S (1996) Schizophrenic deficits in the processing of context: a test of a theoretical model. Arch Gen Psychiatry 53:1105-1112
39. Sesack SR, Deutch AY, Roth RH, Bunney BS (1989) Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol 290:213-242
40. Stratta P, Daneluzzo E, Bustini M, Casacchia M, Rossi A (1998) Processing of context information in schizophrenia. Schizophr Res 29:45
41. Stratta P, Daneluzzo E, Bustini M, Prosperini P, Rossi A (2000) Processing of context information in schizophrenia: relation to clinical symptoms and WCST performance. Schizophr Res 44:57-67
42. Suzuki Y, Jodo E, Takeuchi S, Niwa S, Kayama Y (2002) Acute administration of phencyclidine induces tonic activation of medial prefrontal cortex neurons in freely moving rats. Neuroscience 114:769-779
43. Tanii Y, Nishikawa T, Umino A, Takahashi K (1990) Phencyclidine increases extracellular dopamine metabolites in rat medial frontal cortex as measure by in vivo dialysis. Neurosci Lett 112:318-323
44. Thierry AM, Blanc G, Sobel A, Stinus L, Glowinski J (1973) Dopaminergic terminals in the rat cortex. Science 182:499-501
45. Tzschentke TM (2001) Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol 63:241-320
46. Umbricht D, Schmid L, Koller R, Vollenweider FX, Hell D, Javitt DC (2000) Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch Gen Psychiatry 57:1139-1147
47. Weinberger DR, Berman KF, Zek RF (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 43:114-124
48. Williams SM, Goldman-Rakic PS (1993) Characterization of the dopaminergic innervation of the primate frontal cortex using a dopamine-specific antibody. Cereb Cortex 3:199-222